This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Perioperative care

Authoring team

The patient undergoing total hip replacement should be informed of the general risks of the general anaesthetic and of major surgery.

The effects of infection in a prosthetic hip are disastrous. Prophylactic antibiotic cover is given about half an hour prior to surgery and continued for 24-48 hours afterwards until the drains are removed.

A hip replacement is a major operation and prophylactic anticoagulant therapy is recommended. Usually, subcutaneous heparin or one of the newer low molecular weight heparins are prescribed. In some series, fatal pulmonary embolism occurs in 1-2% of total hip replacements not covered pre-operatively by suitable anticoagulant therapy.

Post-operatively, weight bearing should be gradually introduced. Some recommend that the patient should remain on crutches for 6-10 weeks until osteointegration is advanced.

Patients should be informed that the new hip may dislocate so certain positions such as sitting in a low chair are to be avoided. Activities which involve repetitive impact such as tennis and jogging are out of the question but more gentle exercise such as swimming, cycling and golf are to be encouraged.

The patient should also be aware that the hip may loosen and require replacement. They will be encouraged that they will have complete relief from hip pain.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.